Artelo Biosciences, Inc. SEC filings ARTL
Artelo Biosciences, Inc. has 465 filings in SEC EDGAR's recent list, going back to Oct 8, 2014. Its latest annual report, Form ARS, was filed on Jun 5, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 9, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Jul 16, 2026 | — |
| DEFA14A | Additional proxy material | Jul 16, 2026 | — |
| DEFA14A | Additional proxy material | Jul 2, 2026 | — |
| DEFA14A | Additional proxy material | Jun 5, 2026 | — |
| DEF 14A | Proxy statement | Jun 5, 2026 | Jul 17, 2026 |
| PRE 14A | Preliminary proxy statement | May 26, 2026 | Jul 17, 2026 |
| DEFA14A | Additional proxy material | Jan 7, 2026 | — |
| DEF 14A | Proxy statement | Dec 11, 2025 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Aug 7, 2025 | Aug 28, 2025 |
| PRE 14A | Preliminary proxy statement | Jul 28, 2025 | Aug 28, 2025 |
| DEFA14A | Additional proxy material | Nov 8, 2024 | — |
| DEF 14A | Proxy statement | Nov 8, 2024 | Dec 19, 2024 |
| DEFA14A | Additional proxy material | May 16, 2023 | — |
| DEF 14A | Proxy statement | May 16, 2023 | May 5, 2023 |
| PRE 14A | Preliminary proxy statement | May 5, 2023 | Apr 14, 2023 |
| DEFA14A | Additional proxy material | May 26, 2022 | — |
| DEF 14A | Proxy statement | May 26, 2022 | May 16, 2022 |
| PRE 14A | Preliminary proxy statement | May 16, 2022 | May 16, 2022 |
| DEFA14A | Additional proxy material | Jun 22, 2021 | — |
| DEF 14A | Proxy statement | May 7, 2021 | May 7, 2021 |
| DEF 14A | Proxy statement | Nov 9, 2020 | Nov 9, 2020 |
| PRE 14A | Preliminary proxy statement | Oct 28, 2020 | Oct 28, 2020 |
| DEF 14A | Proxy statement | May 8, 2020 | May 8, 2020 |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ARTL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Solana Beach, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1621221
- Former names
- REACTIVE MEDICAL INC. (until Apr 17, 2017); KNIGHT KNOX DEVELOPMENT CORP. (until Feb 6, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.